Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation
- PMID: 11108288
- DOI: 10.1210/endo.141.12.7848
Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation
Abstract
Transforming growth factor-beta (TGF-beta) is a multifunctional regulator of a variety of cellular functions, including proliferation, differentiation, matrix synthesis, and apoptosis. In growth plate chondrocytes, TGF-beta slows the rate of maturation. Because the current paradigm of TGF-beta signaling involves Smad proteins as downstream regulators of target genes, we have characterized their role as mediators of TGF-beta effects on chondrocyte maturation. Both Smad2 and 3 translocated to the nucleus upon TGF-beta1 signaling, but not upon BMP-2 signaling. Cotransfection experiments using the TGF-beta responsive and Smad3 sensitive p3TP-Lux luciferase reporter demonstrated that wild-type Smad3 potentiated, whereas dominant negative Smad3 inhibited TGF-beta1 induced luciferase activity. To confirm the role of Smad2 and 3 as essential mediators of TGF-beta1 effects on chondrocyte maturation, we overexpressed both wild-type and dominant negative Smad2 and 3 in virally infected chondrocyte cultures. Overexpression of both wild-type Smad2 and 3 potentiated the inhibitory effect of TGF-beta on chondrocyte maturation, as determined by colx and alkaline phosphatase activity, whereas dominant negative Smad2 and 3 blocked these effects. Wild-type and dominant negative forms of Smad3 had more pronounced effects than Smad2. Our results define Smad2 and 3 as key mediators of the inhibitory effect of TGF-beta1 signaling on chondrocyte maturation.
Similar articles
-
TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.Arch Oral Biol. 2004 Nov;49(11):911-8. doi: 10.1016/j.archoralbio.2004.05.005. Arch Oral Biol. 2004. PMID: 15353247
-
ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation.Exp Cell Res. 2003 Aug 1;288(1):198-207. doi: 10.1016/s0014-4827(03)00181-2. Exp Cell Res. 2003. PMID: 12878171
-
Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta.Ann N Y Acad Sci. 2003 May;995:1-10. doi: 10.1111/j.1749-6632.2003.tb03205.x. Ann N Y Acad Sci. 2003. PMID: 12814934 Review.
-
Smad-Runx interactions during chondrocyte maturation.J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S15-22. J Bone Joint Surg Am. 2001. PMID: 11263661 Review.
-
The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.Kidney Int. 1999 Oct;56(4):1354-65. doi: 10.1046/j.1523-1755.1999.00680.x. Kidney Int. 1999. PMID: 10504488
Cited by
-
Integrative Analysis Reveals the Diverse Effects of 3D Stiffness upon Stem Cell Fate.Int J Mol Sci. 2023 May 26;24(11):9311. doi: 10.3390/ijms24119311. Int J Mol Sci. 2023. PMID: 37298263 Free PMC article.
-
Single-cell RNA sequencing analysis of human chondrocytes reveals cell-cell communication alterations mediated by interactive signaling pathways in osteoarthritis.Front Cell Dev Biol. 2023 Apr 4;11:1099287. doi: 10.3389/fcell.2023.1099287. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37082621 Free PMC article.
-
Chondrocyte Hypertrophy in Osteoarthritis: Mechanistic Studies and Models for the Identification of New Therapeutic Strategies.Cells. 2022 Dec 13;11(24):4034. doi: 10.3390/cells11244034. Cells. 2022. PMID: 36552796 Free PMC article. Review.
-
An integrated in silico-in vitro approach for identifying therapeutic targets against osteoarthritis.BMC Biol. 2022 Nov 9;20(1):253. doi: 10.1186/s12915-022-01451-8. BMC Biol. 2022. PMID: 36352408 Free PMC article.
-
Is "cellular senescence" a misnomer?Geroscience. 2022 Oct;44(5):2461-2469. doi: 10.1007/s11357-022-00652-x. Epub 2022 Sep 7. Geroscience. 2022. PMID: 36068483 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources